Metacrine Company
Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseases
Headquarters:
San Diego, California, United States
Last Funding Type:
Debt Financing
Investors Number:
14
Last Funding Date:
2019
Employee Number:
11-50
Total Funding:
173000000
Founded Date:
2015
Technology:
Immunotherapy
Estimated Revenue:
$10M to $50M
Investor Type:
IPO
Industry:
Biotechnology, Health Care, Medical, Pharmaceutical
Funding Status:
IPO